ASCs harvested from obese individuals (obASCs) generate increased leptin which leads to increased downstream estrogen levels and thus increased proliferation in the case of estrogen receptor-positive (ER+) breast cancer, with the non-estrogen leptin pathway promoting metastasis even in non-ER+ breast cancer (Sabol et al., 2019b). Here, LEP is linked to breast carcinoma.